Stem Cells World Congress
Recommend Cell Cycle to your librarian for 2008. Download form here.

Sign up for Table of Contents Alerts.

Cell Cycle is published 24 times a year.

home subscribe search archive forthcoming

Email this page Print this page

Reports

Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of Aurora B

Renske J. van Leuken, Mark P. Luna-Vargas, Titia K. Sixma, Rob M.F. Wolthuis and René H. Medema

volume 7 | issue 17

1 September 2008
Pages: 2710 - 2719

This is an open-access article

 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.

Accurate chromosome segregation relies on the mitotic spindle checkpoint. This checkpoint acts to restrict ubiquitin ligase activity of the Anaphase-promoting complex (APC/C) in mitosis until all chromosomes are bipolarly attached to the mitotic spindle. We performed a functional RNAi-based screen to identify De-ubiquitinating enzymes (Dubs) involved in mitotic progression. We identified Usp39 as a new factor required to maintain the spindle checkpoint and support successful cytokinesis. Strikingly, although Usp39 clearly contains an ubiquitin-protease domain, we show that Usp39 is entirely deprived of Dub activity. However, consistent with a previously described role for Usp39 in mRNA processing, we observed specific reduction in Aurora B-mRNA levels after depletion of Usp39. Although we find that exogenously expressed Aurora B cDNA is not sufficient to rescue the checkpoint defect of Usp39-depleted cells, Aurora B expression is restored. Our observations suggest Usp39 to be involved in splicing of Aurora B and other mRNAs that are essential for proper spindle checkpoint function.

Authors

Renske J. van Leuken

University Medical Center Utrecht; Utrecht, The Netherlands

Mark P. Luna-Vargas

The Netherlands Cancer Institute; Amsterdam, The Netherlands

Titia K. Sixma

The Netherlands Cancer Institute; Amsterdam, The Netherlands

Rob M.F. Wolthuis

The Netherlands Cancer Institute; Amsterdam, The Netherlands

René H. Medema

University Medical Center Utrecht; Utrecht, The Netherlands


This is an open-access article

 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.